SG11202005947RA - Implantable device for sustained release of a macromolecular drug compound - Google Patents

Implantable device for sustained release of a macromolecular drug compound

Info

Publication number
SG11202005947RA
SG11202005947RA SG11202005947RA SG11202005947RA SG11202005947RA SG 11202005947R A SG11202005947R A SG 11202005947RA SG 11202005947R A SG11202005947R A SG 11202005947RA SG 11202005947R A SG11202005947R A SG 11202005947RA SG 11202005947R A SG11202005947R A SG 11202005947RA
Authority
SG
Singapore
Prior art keywords
sustained release
implantable device
drug compound
macromolecular drug
macromolecular
Prior art date
Application number
SG11202005947RA
Inventor
Christian Schneider
Original Assignee
Celanese Eva Performance Polymers Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celanese Eva Performance Polymers Corp filed Critical Celanese Eva Performance Polymers Corp
Publication of SG11202005947RA publication Critical patent/SG11202005947RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22004—Bromelain (3.4.22.4)
SG11202005947RA 2018-05-24 2019-05-20 Implantable device for sustained release of a macromolecular drug compound SG11202005947RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862675982P 2018-05-24 2018-05-24
PCT/US2019/033059 WO2019226516A1 (en) 2018-05-24 2019-05-20 Implantable device for sustained release of a macromolecular drug compound

Publications (1)

Publication Number Publication Date
SG11202005947RA true SG11202005947RA (en) 2020-07-29

Family

ID=68615393

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005947RA SG11202005947RA (en) 2018-05-24 2019-05-20 Implantable device for sustained release of a macromolecular drug compound

Country Status (11)

Country Link
US (2) US11690807B2 (en)
EP (1) EP3801462A4 (en)
JP (2) JP2021524841A (en)
KR (1) KR20210013088A (en)
CN (1) CN111971026A (en)
AU (1) AU2019275406A1 (en)
BR (1) BR112020023983A2 (en)
CA (1) CA3087238A1 (en)
MX (1) MX2020012458A (en)
SG (1) SG11202005947RA (en)
WO (1) WO2019226516A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202005949UA (en) 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
BR112020023983A2 (en) 2018-05-24 2021-02-23 Celanese Eva Performance Polymers Llc implantable device for prolonged release of a macromolecular drug compound
WO2021219576A1 (en) * 2020-04-27 2021-11-04 Grünenthal GmbH Multiparticulate dosage form containing eva copolymer and additional excipient
BR112023022439A2 (en) * 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc IMPLANTABLE DEVICE FOR SUSTAINED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
US20230047191A1 (en) * 2021-08-05 2023-02-16 Celanese Eva Performance Polymers Llc Implantable Medical Device for the Delivery of Bisphosphonate
US20230233455A1 (en) * 2022-01-24 2023-07-27 Celanese Eva Performance Polymers Llc Method for Prohibiting and/or Treating an Eye Condition
WO2023172387A1 (en) * 2022-03-08 2023-09-14 Celanese Eva Performance Polymers Llc Implantable medical device for the delivery of aromatase inhibitor
WO2023244526A1 (en) * 2022-06-13 2023-12-21 Celanese Eva Performance Polymers Llc Monolithic implantable device for sustained release of an antibody
WO2024011230A1 (en) * 2022-07-07 2024-01-11 Nacuity Pharmaceuticals, Inc. Ophthalmic implant

Family Cites Families (291)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4391797A (en) 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4164560A (en) 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4357312A (en) 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4863735A (en) 1985-02-19 1989-09-05 Massachusetts Institute Of Technology Biodegradable polymeric drug delivery system with adjuvant activity
US4900556A (en) 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4952406A (en) 1985-06-27 1990-08-28 The Children's Medical Center Corporation Feedback controlled release
US4663147A (en) 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
US5008112A (en) 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US4933185A (en) 1986-09-24 1990-06-12 Massachusetts Institute Of Technology System for controlled release of biologically active compounds
US4883666A (en) 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5601835A (en) 1987-04-29 1997-02-11 Massachusetts Institute Of Technology Polymeric device for controlled drug delivery to the CNS
US4792448A (en) 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
DE19975054I2 (en) * 1987-08-08 2000-04-13 Akzo Nobel Nv Contraceptive implant
US4898734A (en) 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
US5100668A (en) 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
US5356630A (en) 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5439688A (en) 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US4989734A (en) 1990-05-29 1991-02-05 Mode Ronald L Order filler and supply container apparatus
HU208495B (en) 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5330768A (en) 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5340581A (en) 1991-08-23 1994-08-23 Gillette Canada, Inc. Sustained-release matrices for dental application
US5302397A (en) 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US5512293A (en) 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
DE4308807A1 (en) * 1993-03-19 1994-09-22 Gambro Dialysatoren Process for the production of hydrophilic membranes
US5543465A (en) 1993-03-19 1996-08-06 Gambro Dialysatoren Gmbh & Co. Process for the production of hydrophilic membranes
CA2176145C (en) 1993-11-15 2007-04-10 Vernon G. Wong Biocompatible ocular implants
AU710504B2 (en) 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
US8795242B2 (en) 1994-05-13 2014-08-05 Kensey Nash Corporation Resorbable polymeric device for localized drug delivery
US5633000A (en) 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
AUPM897594A0 (en) 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
DE4441575C2 (en) 1994-11-22 1998-08-06 Bruker Analytische Messtechnik Device and method for quickly discharging a superconducting magnet coil
US6281015B1 (en) 1994-12-16 2001-08-28 Children's Medical Center Corp. Localized delivery of factors enhancing survival of transplanted cells
IL112834A (en) 1995-03-01 2000-12-06 Yeda Res & Dev Pharmaceutical compositions for controlled release of soluble receptors
DE69616551T2 (en) 1995-07-04 2002-05-29 Akzo Nobel Nv RING-SHAPED DEVICE
US5877224A (en) 1995-07-28 1999-03-02 Rutgers, The State University Of New Jersey Polymeric drug formulations
CA2184316A1 (en) 1995-09-12 1997-03-13 Wei-Chi Liao Buccal delivery system for therapeutic agents
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6586401B1 (en) 1996-02-16 2003-07-01 Children's Medical Center Corporation Troponin subunit I fragment and homologs thereof
US5733565A (en) 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
AU765149B2 (en) 1996-04-08 2003-09-11 New York University Medical Center Method for gene transfer to the central nervous system
US6210664B1 (en) 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system
ATE359805T1 (en) 1996-08-30 2007-05-15 Peptech Ltd SUSTAINED RELEASE FORMULATION OF GNRH PEPTIDE AGONISTS AND ANALOGS
US5783567A (en) 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
JP3966481B2 (en) * 1997-02-18 2007-08-29 東レ株式会社 Semipermeable membrane
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US10028851B2 (en) * 1997-04-15 2018-07-24 Advanced Cardiovascular Systems, Inc. Coatings for controlling erosion of a substrate of an implantable medical device
WO1999009149A1 (en) 1997-08-01 1999-02-25 Massachusetts Institute Of Technology Three-dimensional polymer matrices
US6096764A (en) 1997-08-21 2000-08-01 Eli Lilly And Company Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
KR20010033834A (en) 1998-01-02 2001-04-25 타이탄 파마슈티칼스 인코퍼레이티드 Use of pigmented retinal epithelial cells for creation of an immune privilege site
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
US20020188037A1 (en) 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
JP3406903B2 (en) 1998-04-27 2003-05-19 サーモディックス，インコーポレイティド Coating releasing bioactive agent
US6730322B1 (en) 1998-04-30 2004-05-04 Acusphere, Inc. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
US6423345B2 (en) 1998-04-30 2002-07-23 Acusphere, Inc. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
US6159143A (en) 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
EP1100473A2 (en) 1998-07-28 2001-05-23 InnerDyne, Inc. Absorbable brachytherapy and chemotherapy delivery devices and methods
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US20040121014A1 (en) 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US7115256B1 (en) 1999-04-09 2006-10-03 Titan Pharmaceuticals, Inc. Methods of treating schizophrenia
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6767550B1 (en) 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
JP4471568B2 (en) 2000-08-30 2010-06-02 ジョンズ・ホプキンス・ユニバーシティ Intraocular drug delivery device
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
WO2003026718A1 (en) 2000-10-31 2003-04-03 Cook Incorporated Coated implantable medical device
JP2004521882A (en) 2001-01-03 2004-07-22 ボシュ・アンド・ロム・インコーポレイテッド Sustained release drug delivery device with assembled permeable plug
EP1365738A2 (en) 2001-01-26 2003-12-03 Bausch & Lomb Incorporated Improved process for the production of sustained release drug delivery devices
GB0104383D0 (en) 2001-02-22 2001-04-11 Psimedica Ltd Cancer Treatment
US6713081B2 (en) 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
EP1382350A4 (en) 2001-04-25 2006-01-04 Takeda Pharmaceutical Preventives for postoperative recurrence of premenopausal breast cancer
US20040022853A1 (en) 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
JP2003137814A (en) 2001-08-10 2003-05-14 Takeda Chem Ind Ltd COMBINED PHARMACEUTICAL OF GnRH AGONIST
RU2311892C2 (en) 2001-08-29 2007-12-10 КАРВАЛХО Рикардо А. П. ДЕ Implantable sealable system for one-way delivery of therapeutic preparations to tissues
US7989018B2 (en) 2001-09-17 2011-08-02 Advanced Cardiovascular Systems, Inc. Fluid treatment of a polymeric coating on an implantable medical device
US20030149008A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Hormonal implants treatment of the breast cancer
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
DE10208344A1 (en) 2002-02-27 2003-09-04 Roehm Gmbh Melt extrusion of active ingredient salts
US20030203000A1 (en) 2002-04-24 2003-10-30 Schwarz Marlene C. Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques
AU2003217531A1 (en) 2002-05-02 2003-11-17 Massachusetts Eye And Ear Infirmary Ocular drug delivery systems and use thereof
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003240493B2 (en) 2002-05-31 2008-06-12 L. Molteni & C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. Implantable polymeric device for sustained release of buprenorphine
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
AU2003251942A1 (en) 2002-07-17 2004-02-02 Titan Pharmaceuticals, Inc. Combination of chemotherapeutic drugs for increasing antitumor activity
DE10250543A1 (en) 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Multilayer dosage form
US7189461B2 (en) 2003-03-04 2007-03-13 Air Products Polymers, L.P. Semi-crystalline ethylene vinyl acetate emulsion polymers for heat seal applications
AU2004228017C1 (en) 2003-03-31 2010-06-03 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
US7598287B2 (en) 2003-04-01 2009-10-06 Medical College Of Georgia Research Institute, Inc. Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
CA2523859C (en) 2003-04-29 2011-08-02 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
JP4824549B2 (en) 2003-05-02 2011-11-30 サーモディクス，インコーポレイティド Controlled release bioactive substance delivery device
US20040224000A1 (en) 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
US7279174B2 (en) 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
EP1638536A2 (en) 2003-05-30 2006-03-29 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
DE10332160A1 (en) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multiparticulate dosage form containing mucoadhesively formulated peptide or protein active substances, and a method for producing the dosage form
US20050159676A1 (en) 2003-08-13 2005-07-21 Taylor James D. Targeted biopsy delivery system
CA2448995A1 (en) 2003-11-12 2005-05-12 James Keenan Device and method for attracting diseased cells and foreign substances
US20060141049A1 (en) 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
CA2550119A1 (en) 2003-12-17 2005-06-30 Titan Pharmaceuticals, Inc. Use of gallium to treat inflammatory arthritis
EP2286791B1 (en) 2003-12-30 2014-03-26 Durect Corporation Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
WO2005087221A1 (en) 2004-03-15 2005-09-22 Christine Allen Biodegradable biocompatible implant and method of manufacturing same
TWI434676B (en) 2004-03-19 2014-04-21 Merck Sharp & Dohme X-ray visible drug delivery device
JP2007530500A (en) 2004-03-24 2007-11-01 ナームローゼ・フエンノートチヤツプ・オルガノン Drug delivery system based on polyethylene vinyl acetate copolymer
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20050244462A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
EP1768692B8 (en) 2004-07-01 2015-06-17 Yale University Targeted and high density drug loaded polymeric materials
US20060110428A1 (en) 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
DE102004036437A1 (en) 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multiparticulate dosage form for sparingly soluble active ingredients, as well as a method for producing the dosage form
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
US7594899B2 (en) 2004-12-03 2009-09-29 Innfocus, Llc Glaucoma implant device
DE102004059792A1 (en) 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multiparticulate dosage form containing mucoadhesively formulated nucleic acid active ingredients, and a method for producing the dosage form
WO2006063242A1 (en) 2004-12-10 2006-06-15 Titan Pharmaceuticals, Inc. Methods and compositions for induction of tumor regression
US20060127463A1 (en) 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
JP2008524235A (en) 2004-12-15 2008-07-10 キューエルティー ユーエスエー，インコーポレイテッド． Sustained release delivery formulation for octreotide compounds
US20060188543A1 (en) 2005-01-31 2006-08-24 Si-Shen Feng Nanoparticle coating for drug delivery
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US7531503B2 (en) 2005-03-11 2009-05-12 Wake Forest University Health Sciences Cell scaffold matrices with incorporated therapeutic agents
JP5756588B2 (en) 2005-07-15 2015-07-29 ミセル テクノロジーズ、インコーポレイテッド Polymer coating containing controlled morphological drug powder
US8858993B2 (en) 2005-07-25 2014-10-14 Metrics, Inc. Coated tablet with zero-order or near zero-order release kinetics
CA2618349C (en) 2005-08-11 2016-05-31 Massachusetts Institute Of Technology Intravesical drug delivery device and method
ES2556974T3 (en) 2005-08-12 2016-01-21 Jiang Liu Devices for lymphatic system orientation
US20070212397A1 (en) 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
KR100648519B1 (en) 2005-10-21 2006-11-27 주식회사 컴테크케미칼 Ethylene vinyl acetate based polymer foams with low density and injection preparation method thereof
EP1945273A1 (en) 2005-11-07 2008-07-23 Titan Pharmaceuticals, Inc. Treatment and prevention of adverse liver conditions using gallium
US20070134332A1 (en) 2005-11-21 2007-06-14 Medivas, Llc Polymer particles for delivery of macromolecules and methods of use
US10029034B2 (en) 2005-12-15 2018-07-24 CARDINAL HEALTH SWITZERLAND 515 GmbH Drug-eluting articles with improved drug release profiles
CN101385698A (en) 2005-12-20 2009-03-18 济南康泉医药科技有限公司 Anti-cancer sustained-released implantation agent
EP1978976A2 (en) 2006-01-30 2008-10-15 Titan Pharmaceuticals, Inc. Use of gallium to treat biofilm-associated infectons
PL1978936T3 (en) 2006-02-03 2013-11-29 Evonik Roehm Gmbh Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water
WO2007112946A1 (en) 2006-03-30 2007-10-11 Universite De Geneve Intraocular lens with drug delivery system attached thereto
US20070260203A1 (en) 2006-05-04 2007-11-08 Allergan, Inc. Vasoactive agent intraocular implant
WO2007139744A2 (en) 2006-05-23 2007-12-06 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
DE102006035549A1 (en) 2006-07-27 2008-01-31 Evonik Röhm Gmbh Pharmaceutical form with at least two-layer separating layer
ES2385498T3 (en) 2006-08-18 2012-07-25 Evonik Röhm Gmbh Pharmaceutical composition with controlled release of the active substance, for active substances with good water solubility
US8039010B2 (en) 2006-11-03 2011-10-18 Allergan, Inc. Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
MX2009005445A (en) 2006-11-22 2009-06-02 Organon Nv Delivery system for risperidone.
WO2008076544A2 (en) 2006-12-18 2008-06-26 Alcon Research, Ltd. Devices and methods for ophthalmic drug delivery
US8580735B2 (en) 2007-02-05 2013-11-12 Apellis Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
CN101011345A (en) 2007-02-12 2007-08-08 济南帅华医药科技有限公司 Slow release injection containing platinum compound and alkylating agent
AU2008219585A1 (en) 2007-02-27 2008-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
JP2010531807A (en) 2007-05-25 2010-09-30 トルマー セラピューティクス， インコーポレイテッド Slow-broadcast formulation of risperidone compound
ES2696999T3 (en) 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Devices for the intravaginal administration of drugs for the administration of macromolecules and water-soluble drugs
US20090035381A1 (en) 2007-08-01 2009-02-05 Stankus John J Electrospraying method for fabrication of particles and coatings and treatment methods thereof
EP2207529B1 (en) 2007-09-07 2014-12-31 Mati Therapeutics Inc. Drug cores for sustained release of therapeutic agents
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US20100303883A1 (en) 2007-10-17 2010-12-02 Axxia Pharmaceuticals, Llc Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
WO2009094573A2 (en) 2008-01-25 2009-07-30 The University Of Utah Research Foundation Linear order release polymer
CN102006891B (en) 2008-02-13 2017-04-26 哈佛学院董事会 Continuous cell programming devices
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
EP2254857A4 (en) 2008-02-21 2014-06-25 Univ Rutgers Compositions and methods for treating ophthalmic diseases
WO2009129459A1 (en) 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
US8496954B2 (en) * 2008-04-18 2013-07-30 Surmodics, Inc. Coating systems for the controlled delivery of hydrophilic bioactive agents
WO2009134371A2 (en) 2008-04-30 2009-11-05 Qlt Plug Delivery, Inc. Composite lacrimal insert and related methods
US8795707B2 (en) 2008-05-13 2014-08-05 Trustees Of Boston University Compliant composites for application of drug-eluting coatings to tissue surfaces
DE102008002395A1 (en) 2008-06-12 2009-12-17 Biotronik Vi Patent Ag Drug-loaded implant
WO2009158412A2 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
WO2010033771A2 (en) 2008-09-19 2010-03-25 Trustees Of The University Of Pennsylvania Modulators of hsp70/dnak function and methods of use thereof
US9078900B2 (en) 2008-09-30 2015-07-14 Braeburn Pharmaceuticals Bvba Sprl Implantable device for the delivery of risperidone and methods of use thereof
EP2352544A4 (en) 2008-11-07 2013-12-25 Combinent Biomedical Systems Inc Devices and methods for treating and/or preventing diseases
CA2743335A1 (en) 2008-11-20 2010-05-27 Insight Innovations, Llc Biocompatible biodegradable intraocular implant system
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
LT2381932T (en) 2009-01-29 2018-11-12 Fondazione Irccs Istituto Nazionale Dei Tumori Intra-cervical device for the release of drugs in the local- regional treatment of cervical cancer
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
TW201034641A (en) 2009-02-28 2010-10-01 Charles Knezevich Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
AR075846A1 (en) 2009-03-17 2011-04-27 Organon Nv FARMACO ADMINISTRATION SYSTEM OF LACTONA MACROCICLICA.USO. TREATMENT METHOD
CN102655823B (en) 2009-05-18 2016-04-20 多斯医学公司 Medicament elution ocular implant
FI20095550A0 (en) 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginal delivery system
FI20095563A (en) 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginal delivery system
HUE035519T2 (en) 2009-07-08 2018-05-02 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions
WO2011007353A1 (en) 2009-07-14 2011-01-20 Polypid Ltd. Sustained-release drug carrier composition
AU2010274946B2 (en) 2009-07-21 2013-09-12 The Population Council, Inc. Multi-layered gradient vaginal ring
US20110038936A1 (en) 2009-08-17 2011-02-17 Kimberly Ann Griswold System and method for electrospun drug loaded biodegradable chemotherapy applications
US20110105990A1 (en) 2009-11-04 2011-05-05 Silvestrini Thomas A Zonal drug delivery device and method
EP2533737B1 (en) 2010-02-08 2014-01-08 On Demand Therapeutics, Inc. Low-permeability, laser-activated drug delivery device
MX346316B (en) 2010-02-25 2017-03-15 Evonik Roehm Gmbh Pharmaceutical or neutraceutical formulation.
PT2547332T (en) * 2010-03-16 2018-11-27 Titan Pharmaceuticals Inc Heterogeneous implantable devices for drug delivery
US20130273137A1 (en) 2010-05-03 2013-10-17 Massachusetts Eye & Ear Infirmary Drug delivery coating and devices
US20130142858A1 (en) 2010-05-17 2013-06-06 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
US8747883B2 (en) 2010-06-02 2014-06-10 Princeton Trade & Technology, Inc. Medical item for long term drug release
US8236857B2 (en) * 2010-07-08 2012-08-07 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof
US20120029042A1 (en) 2010-07-30 2012-02-02 Warsaw Orthopedic, Inc. Clonidine for treatment of bone cancer
WO2012021108A1 (en) 2010-08-12 2012-02-16 Nanyang Technological University A biodegradable ocular implant
US9370444B2 (en) 2010-10-12 2016-06-21 Emmett T. Cunningham, JR. Subconjunctival conformer device and uses thereof
US8900616B2 (en) 2010-10-22 2014-12-02 Covidien Lp System and method for satellite drug delivery
US20130287688A1 (en) 2010-11-18 2013-10-31 Xtuit Pharmaceuticals, Inc. Novel compositions and uses of anti-hypertension agents for cancer therapy
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
AU2012214146A1 (en) 2011-02-11 2013-08-29 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics
WO2012142328A2 (en) 2011-04-12 2012-10-18 Ratner Buddy D Polymer microsphere compositions for localized delivery of therapeutic agents
WO2012149492A1 (en) 2011-04-27 2012-11-01 Massachusetts Institute Of Technology Coating compositions, methods and coated devices
ES2456917T3 (en) 2011-05-31 2014-04-24 Laboratorios Farmacéuticos Rovi, S.A. Paliperidone implant formulation
LT2529756T (en) 2011-05-31 2021-07-26 Laboratorios Farmaceuticos Rovi, S.A. Risperidone and/or paliperidone implant formulation
PL2720681T3 (en) 2011-06-17 2017-05-31 Evonik Röhm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms
WO2012171884A1 (en) 2011-06-17 2012-12-20 Evonik Röhm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
WO2012171575A1 (en) 2011-06-17 2012-12-20 Evonik Röhm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms
WO2012177968A1 (en) 2011-06-22 2012-12-27 The Schepens Eye Research Institute, Inc. A scaffold for subretinal cell transplantation and drug delivery
KR20140074281A (en) 2011-07-20 2014-06-17 패트릭 에프. 카이저 Intravaginal devices for drug delivery
WO2013052721A1 (en) 2011-10-05 2013-04-11 Applied Nanotech Holdings, Inc. Sintering metallic inks on low melting point substrates
WO2013063079A1 (en) 2011-10-24 2013-05-02 Endo Pharmaceuticals Solutions Inc. Implantable tizanidine compositions and methods of treatment thereof
EP2591770B1 (en) 2011-11-14 2016-03-16 Silenseed Ltd Compositions for siRNA delivery and methods of manufacturing and using same
BR112014014600A2 (en) 2011-12-16 2017-06-13 Combinent Biomedical Systems Inc devices for vaginal drug delivery and manufacturing methods
US20140348936A1 (en) * 2011-12-16 2014-11-27 Celanese Eva Performance Polymers, Inc. Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermoplastic polyurethanes
TW201332585A (en) 2012-02-14 2013-08-16 Chemo Res S L Core sheath drug delivery devices
WO2013124869A2 (en) 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
DE102013011399A1 (en) 2012-07-31 2014-02-06 Amw Gmbh Rod-shaped biodegradable implant useful for maintenance therapy in schizophrenia in patients comprises risperidone
RU2015110824A (en) 2012-08-27 2016-10-20 Эвоник Индустрис Аг PHARMACEUTICAL OR NUTRICEVITIC COMPOSITION WITH SLOW DELIVERY AND RESISTANCE TO ETHANOL
SI2887925T1 (en) 2012-08-27 2017-06-30 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
EP2708213A1 (en) 2012-09-13 2014-03-19 PAT&Co bvba Multipurpose ethylene vinyl acetate fibrous drug delivery systems for long-term implantation or insertion
ES2709351T3 (en) 2012-09-27 2019-04-16 Allergan Inc Biodegradable drug delivery systems for the sustained release of proteins
US20140128349A1 (en) 2012-11-02 2014-05-08 Indiana University School of Medicine Administering inhibitors of tgfbeta signaling in combination with benzothiazepine derivatives to improve muscle function in cancer patients
AU2013344388A1 (en) 2012-11-19 2015-07-09 Braeburn Pharmaceuticals, Inc. Implantable drug delivery compositions and methods of treatment thereof
WO2014085461A1 (en) 2012-11-29 2014-06-05 The Penn State Research Foundation Photodynamic dhsip anticancer therapeutic and immunomodulator
US20160008399A1 (en) 2013-01-14 2016-01-14 Fred Hutchinson Cancer Research Center Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
US20140212355A1 (en) 2013-01-28 2014-07-31 Abbott Cardiovascular Systems Inc. Trans-arterial drug delivery
BR112015018895A2 (en) 2013-02-13 2017-07-18 Evonik Roehm Gmbh multiparticulate pharmaceutical composition comprising a multiplicity of two types of pellets
JP6511401B2 (en) 2013-02-15 2019-05-15 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ Sustained drug delivery implant
WO2014160155A2 (en) 2013-03-14 2014-10-02 Endo Pharmaceuticals Solutions Inc. Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof
WO2014160026A2 (en) 2013-03-14 2014-10-02 Endo Pharmaceuticals Solutions Inc. Implantable drug delivery compositions comprising sugar-based sorption enhancers and methods of treatment thereof
US20140271765A1 (en) 2013-03-15 2014-09-18 Titan Pharmaceuticals, Inc. Methods and device for treating opioid addiction
SG11201507751YA (en) 2013-03-21 2015-10-29 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
US9301926B2 (en) 2013-04-10 2016-04-05 Massachusetts Institute Of Technology Local drug delivery devices and methods for treating cancer
WO2014176451A1 (en) 2013-04-24 2014-10-30 Trustees Of Tufts College Bioresorbable biopolymer stent
EP3865119A1 (en) 2013-05-02 2021-08-18 Retina Foundation of the Southwest Two-layer ocular implant
EP2994113A1 (en) 2013-05-09 2016-03-16 Evonik Röhm GmbH Process for stabilizing the drug release profiles of polymer film coated pharmaceutical compositions
KR20160031526A (en) 2013-07-12 2016-03-22 그뤼넨탈 게엠베하 Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015013716A1 (en) 2013-07-26 2015-01-29 The Regents Of The University Of California Patient-specific temporary implants for accurately guiding local means of tumor control along patient-specific internal channels to treat cancers
CN103435424B (en) 2013-09-02 2016-03-30 济宁道淼新材料科技有限公司 A kind of slow controlled release coated fertilizer of the pbz polymer micro-nano grain of rice
EP3068372B1 (en) 2013-11-14 2019-05-08 EyeD Pharma Eye device
JP6675307B2 (en) 2013-11-15 2020-04-01 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ Methods of treating ocular conditions with sustained drug delivery implants
WO2015085234A1 (en) 2013-12-06 2015-06-11 Forsight Vision4, Inc. Implantable therapeutic devices
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3107529A1 (en) 2014-02-17 2016-12-28 Evonik Röhm GmbH Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
US20150306230A1 (en) 2014-04-28 2015-10-29 Celanese Acetate Llc Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof
JP7348708B2 (en) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Combination vaccine device and method for killing cancer cells
US20150342894A1 (en) 2014-05-30 2015-12-03 Textile-Based Delivery, Inc. Drug delivery systems and related methods of use
TWI522099B (en) 2014-06-04 2016-02-21 中國醫藥大學 Pharmaceutical formulation for treating pancreatic cancer and uses of the same
JP6691715B2 (en) 2014-08-19 2020-05-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Implants for local drug delivery and their use
US10226419B2 (en) 2014-09-08 2019-03-12 ProMed Pharma, LLC Methods for manufacturing implants
MX2017003638A (en) 2014-09-19 2017-11-08 Eupraxia Pharmaceuticals Inc Injectable microparticles for hyper-localized release of therapeutic agents.
WO2016064959A1 (en) 2014-10-21 2016-04-28 Odin Biotech Two-layer ocular implant comprising a tyrosine kinase inhibitor
FR3028410A1 (en) 2014-11-18 2016-05-20 Pierre Coulon MULTIFUNCTIONAL CAPSULAR IMPLANT
CA2967722A1 (en) 2014-11-26 2016-06-02 Evonik Rohm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
US11096888B2 (en) 2015-05-13 2021-08-24 Bayer Oy Long acting drug delivery device and its use in contraception
US20180125780A1 (en) 2015-05-15 2018-05-10 The Methodist Hospital System Implantable nanochannel delivery devices
WO2016187355A1 (en) 2015-05-20 2016-11-24 Glaukos Corporation Therapeutic drug compositions and implants for delivery of same
HUE052340T2 (en) 2015-06-05 2021-05-28 Evonik Operations Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
BR112017026746B1 (en) 2015-06-18 2023-11-28 Acuitybio Corporation Implantable drug delivery compositions and use of a mixture comprising Plga copolymer, peg 8000 and paclitaxel
US9956172B2 (en) 2015-07-28 2018-05-01 Board Of Regents, The University Of Texas System Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
WO2017027874A1 (en) 2015-08-13 2017-02-16 Northeastern University Biomaterials for combined radiotherapy and immunotherapy of cancer
WO2017040855A1 (en) 2015-09-02 2017-03-09 Dose Medical Corporation Drug delivery implants as intraocular drug depots and methods of using same
US9896576B2 (en) * 2015-10-29 2018-02-20 Celanese EVA Performance Polymers Corporation Medical tube
PT109154B (en) 2016-02-12 2019-11-05 Univ De Coimbra NON-INVASIVE EYE INSERT TECHNOLOGY FOR CONTROLLED DRUG RELEASE
CN109477085B (en) 2016-04-22 2023-08-01 萨鲁德医疗公司 Methods and compositions for enhancing anti-inflammatory effects of interleukin 10
US20200316159A1 (en) 2016-06-03 2020-10-08 Jt Pharmaceuticals, Inc. Sustained release compositions of kappa-opioid receptor agonist
EP3468545A4 (en) 2016-06-08 2020-07-22 President and Fellows of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
EP3506884B1 (en) 2016-08-30 2021-05-05 Dana-Farber Cancer Institute, Inc. Drug delivery compositions and uses thereof
WO2018067882A1 (en) 2016-10-05 2018-04-12 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
US20200093852A1 (en) 2016-12-13 2020-03-26 Keats NELMS Methods of Treating Ocular Disorders
AU2017376835A1 (en) 2016-12-16 2019-08-01 Field Orthopaedics Pty Ltd A medical implant and a method of coating a medical implant
US10874768B2 (en) 2017-01-20 2020-12-29 Covidien Lp Drug eluting medical device
MX2019009126A (en) 2017-01-31 2020-01-20 Veru Inc COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GANADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS.
JP2021520352A (en) 2018-04-04 2021-08-19 アリヴィオ セラピューティクス， インコーポレイテッド Self-assembled gel for controlled delivery of biopharmaceuticals and method for producing the same
WO2019213128A1 (en) 2018-04-30 2019-11-07 The Brigham And Women's Hospital, Inc. Compositions and therapeutics methods of microrna gene delivery
SG11202005949UA (en) * 2018-05-24 2020-07-29 Celanese Eva Performance Polymers Corp Implantable device for sustained release of a macromolecular drug compound
BR112020023983A2 (en) 2018-05-24 2021-02-23 Celanese Eva Performance Polymers Llc implantable device for prolonged release of a macromolecular drug compound
CA3104513A1 (en) 2018-06-25 2020-01-02 Titan Pharmaceuticals, Inc. Implants for release of lipophilic or amphiphilic pharmaceutical substances
US20210177742A1 (en) 2018-06-25 2021-06-17 Titan Pharmaceuticals, Inc. Loadable porous structures for use as implants
AU2019293242A1 (en) 2018-06-29 2021-02-11 The Johns Hopkins University Magnetic resonance imaging compatible, convection-enhanced delivery cranial implant devices and related methods
WO2020041500A1 (en) 2018-08-21 2020-02-27 Georgia State University Research Foundation, Inc. Treatment of flavivirus infections in humans using mus musculus resistant 2'-5' oligoadenylate synthetase 1b
WO2020077039A1 (en) 2018-10-12 2020-04-16 Synergene Therapeutics, Inc. Methods for reducing side effects of immunotherapy
US20220195458A1 (en) 2019-03-28 2022-06-23 The General Hospital Corporation Engineered adeno-associated (aav) vectors for transgene expression
KR102264231B1 (en) 2019-07-19 2021-06-11 울산과학기술원 Biopolymers and metal-organic frameworks conjugated complexes and uses thereof

Also Published As

Publication number Publication date
CA3087238A1 (en) 2019-11-28
US11951215B2 (en) 2024-04-09
MX2020012458A (en) 2021-04-28
US11690807B2 (en) 2023-07-04
JP2021524841A (en) 2021-09-16
KR20210013088A (en) 2021-02-03
US20190358167A1 (en) 2019-11-28
US20230277470A1 (en) 2023-09-07
WO2019226516A1 (en) 2019-11-28
BR112020023983A2 (en) 2021-02-23
EP3801462A4 (en) 2022-03-16
EP3801462A1 (en) 2021-04-14
AU2019275406A1 (en) 2020-07-16
JP2024028831A (en) 2024-03-05
CN111971026A (en) 2020-11-20

Similar Documents

Publication Publication Date Title
SG11202005947RA (en) Implantable device for sustained release of a macromolecular drug compound
SG11202005949UA (en) Implantable device for sustained release of a macromolecular drug compound
IL278783A (en) Automatic drug delivery device
CA196050S (en) Drug delivery device
PL3684447T3 (en) Accessory device for drug delivery device
IL291155A (en) Drug delivery device
IL291004A (en) Drug delivery device
FI3886944T3 (en) Drug delivery device
EP3522825A4 (en) Implantable devices for drug delivery with reduced burst release
EP4084843A4 (en) Unilateral-driven patch-type drug infusion device
SG11202005535UA (en) Combination drug including tlr7 agonist
IL291415A (en) Drug delivery device
HK1249450B (en) A transdermal drug administration device
IL291295A (en) Drug delivery device
IL268063B1 (en) Drug infusion device
EP3525864C0 (en) Device for delivery of an implant through a catheter
EP3212170A4 (en) Implantable medical devices for extended release of therapeutic agents
GB201806246D0 (en) Microneedle-based stabilisation system for medical devices
EP3641855A4 (en) Time delay mechanism for a hydraulic drug delivery device
IL262062A (en) Implantable ocular drug delivery devices
IL279127A (en) Delivery devices for administering drugs
IL280777A (en) Expandable drug delivery pill
EP3703770A4 (en) A levelling device for positioning of a medical device
IL291154A (en) Drug delivery device
IL290634A (en) Method for external sterilization of drug delivery device